ligand pharmaceuticals is being added to the S&P small cap 600 as of 11-27-13 close
like long wrote, glad you got the discussion started
would you advise where this was mentioned ?
any comments or thoughts ?
glaxo scheduled to release q3 on 10-23-13
vrts2, was focusing on the refrac lymph leuk only. thanks for the reminder on the other readouts
am i correct in that the trial lasts until 12-2014 ?